更改尿崩症名称：尿崩症更名工作组的立场声明。
Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus.
机构信息
Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan.
Department of Pediatric Endocrinology, Newcastle University, Newcastle upon Tyne NE1 7RU, UK.
出版信息
J Clin Endocrinol Metab. 2022 Dec 17;108(1):1-3. doi: 10.1210/clinem/dgac547.
Abstract
Recent data show that patients with a diagnosis of diabetes insipidus (DI) are coming to harm. Here we give the rationale for a name change to arginine vasopressin deficiency and resistance for central and nephrogenic DI, respectively.
摘要
最近的数据表明，患有尿崩症（DI）诊断的患者正在受到伤害。在这里，我们分别为中枢性和肾源性 DI 的精氨酸加压素缺乏和抵抗改名为提供了理由。
相似文献
1
Changing the Name of Diabetes Insipidus: A Position Statement of the Working Group for Renaming Diabetes Insipidus.
J Clin Endocrinol Metab. 2022 Dec 17;108(1):1-3. doi: 10.1210/clinem/dgac547.
2
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.
Eur J Endocrinol. 2022 Oct 14;187(5):P1-P3. doi: 10.1530/EJE-22-0751. Print 2022 Nov 1.
3
Gestational diabetes insipidus: Diagnosis and management.
Best Pract Res Clin Endocrinol Metab. 2020 Sep;34(5):101384. doi: 10.1016/j.beem.2020.101384. Epub 2020 Feb 27.
4
Changing the name of diabetes insipidus: a position statement of The Working Group for Renaming Diabetes Insipidus.
Endocr J. 2022 Nov 28;69(11):1281-1284. doi: 10.1507/endocrj.EJ20220831. Epub 2022 Oct 14.
5
Changing the name of diabetes insipidus: a position statement of the working group to consider renaming diabetes insipidus.
Arch Endocrinol Metab. 2022 Nov 17;66(6):868-870. doi: 10.20945/2359-3997000000528. Epub 2022 Oct 11.
6
New developments and concepts in the diagnosis and management of diabetes insipidus (AVP-deficiency and resistance).
J Neuroendocrinol. 2023 Jan;35(1):e13233. doi: 10.1111/jne.13233. Epub 2023 Jan 22.
7
Diabetes insipidus: diagnosis and treatment of a complex disease.
Cleve Clin J Med. 2006 Jan;73(1):65-71. doi: 10.3949/ccjm.73.1.65.
8
Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency.
Nat Rev Endocrinol. 2024 Aug;20(8):487-500. doi: 10.1038/s41574-024-00985-x. Epub 2024 May 1.
9
Genetics of Diabetes Insipidus.
Endocrinol Metab Clin North Am. 2017 Jun;46(2):305-334. doi: 10.1016/j.ecl.2017.01.002. Epub 2017 Feb 28.
10
Diagnosis and Management of Central Diabetes Insipidus in Adults.
J Clin Endocrinol Metab. 2022 Sep 28;107(10):2701-2715. doi: 10.1210/clinem/dgac381.
引用本文的文献
1
Idiopathic Arginine Vasopressin Deficiency With an Incidental Non-functional Pituitary Microadenoma in an Elderly Diabetic Woman.
Cureus. 2025 Aug 13;17(8):e89995. doi: 10.7759/cureus.89995. eCollection 2025 Aug.
2
Nephrogenic Diabetes Insipidus: Three Decades of Clinical Reality.
Cureus. 2025 Aug 8;17(8):e89635. doi: 10.7759/cureus.89635. eCollection 2025 Aug.
3
A Novel Pathogenic Variant of the Gene Leading to Arginine Vasopressin Resistance Since the Neonatal Period.
Genes (Basel). 2025 Aug 21;16(8):989. doi: 10.3390/genes16080989.
4
'Un-thirsty' hypernatremia.
Endocrinol Diabetes Metab Case Rep. 2025 Jul 24;2025(3). doi: 10.1530/EDM-25-0008. Print 2025 Jul 1.
5
The changing landscape in the evaluation of hypotonic polyuria in children and adolescents: the role of the new copeptin stimulation tests.
J Pediatr Endocrinol Metab. 2025 May 23. doi: 10.1515/jpem-2025-0046.
6
A Pedigree Study of Hereditary Diabetes Insipidus Caused by X Chromosome AVPR2 Gene Mutation.
Int Med Case Rep J. 2025 May 2;18:529-538. doi: 10.2147/IMCRJ.S514461. eCollection 2025.
7
Prognostic Implications of Diabetes Insipidus in Heart Failure Hospitalizations: Insights from the U.S. National Readmissions Database 2016-2021.
J Clin Med. 2025 Mar 28;14(7):2308. doi: 10.3390/jcm14072308.
8
Hashimoto's thyroiditis- What's in a name?
Hormones (Athens). 2025 Apr 2. doi: 10.1007/s42000-025-00646-2.
9
Sex-dependent increases in oxytocin levels in response to intravenous kisspeptin in humans.
Eur J Endocrinol. 2025 Mar 3;192(3):K24-K29. doi: 10.1093/ejendo/lvaf001.
10
Desmopressin prescription safety in adult inpatients: a real-world tertiary centre experience.
Endocr Connect. 2025 Feb 11;14(3). doi: 10.1530/EC-24-0441. Print 2025 Mar 1.
本文引用的文献
1
Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey.
Lancet Diabetes Endocrinol. 2022 Oct;10(10):700-709. doi: 10.1016/S2213-8587(22)00219-4. Epub 2022 Aug 22.
2
Time for change: Renaming Diabetes Insipidus to improve patient safety.
Clin Endocrinol (Oxf). 2018 May;88(5):625-626. doi: 10.1111/cen.13578. Epub 2018 Mar 22.
3
All medical eponyms should be abandoned.
Presse Med. 2008 Feb;37(2 Pt 1):250-1. doi: 10.1016/j.lpm.2007.11.005. Epub 2007 Dec 27.
4
Wegener's granulomatosis.
Lancet. 2006 Apr 22;367(9519):1362-6. doi: 10.1016/S0140-6736(06)68583-8.
5
Declining use of the eponym "Reiter's syndrome" in the medical literature, 1998-2003.
J Am Acad Dermatol. 2005 Oct;53(4):720-3. doi: 10.1016/j.jaad.2005.06.048.
6
Diabetes insipidus: historical aspects.
Pituitary. 2004;7(1):33-8. doi: 10.1023/b:pitu.0000044633.52516.e1.
7
Notes on the history of eponymic idiopathic vasculitis: the diseases of Henoch and Schönlein, Wegener, Churg and Strauss, Horton, Takayasu, Behçet, and Kawasaki.
Arthritis Care Res. 2000 Aug;13(4):237-45. doi: 10.1002/1529-0131(200008)13:4<237::aid-anr8>3.0.co;2-j.
8
Thirst and vasopressin function in normal and disordered states of water balance.
J Lab Clin Med. 1983 Mar;101(3):351-71.
9
The Greek concept of diabetes.
Bull N Y Acad Med. 1972 Sep;48(8):1033-6.
10
The amenorrhoea-galactorrhea syndrome: present diagnostic and therapeutic perspectives.
Acta Eur Fertil. 1975 Dec;6(4):331-8.
Zotero 插件